Pericardial disease in patients treated with immune checkpoint inhibitors.
Jingyi GongZsofia Dora DrobniAmna ZafarThiago QuinagliaSarah HartmannHannah K GilmanVineet K RaghuCarlos GongoraMeghan E SiseRaza M AlviLeyre ZubiriAnju NohriaRyan J SullivanKerry L ReynoldsDaniel A ZlotoffTomas G NeilanPublished in: Journal for immunotherapy of cancer (2022)
ICI use was associated with an increased risk of development of pericardial disease among patients with cancer and a pericardial event on an ICI was associated with a trend towards increase in mortality.